During pregnancy and breastfeeding medicine treatment, appointed in hypothyroidism, must continue. During pregnancy period of pregnancy it’s necessary to increase the dose of the drug because of the high content of thyroxin binding globulin.
The number of hormone thyroid, which is secreted in human milk during lactation, is not enough to have high-quality violations of the child (even in case of treatment of high dosages of the medication). Reception within pregnancy in combination with tireostatics is contraindicated, because the use of Synthroid may need to increase doses tireostatics. Tireostatics, in contrast to the drug can penetrate through the placenta, while there is a chance that the fetus will develop hypothyroidism. Within period of breastfeeding the remedy must be taken with caution, only under the supervision of a doctor in the recommended dosages.
Synthroid Side effects:
When properly used under the supervision of physician Synthroid side effects are not observed, in order to see this, you can explore Synthroid review. The high degree of sensitivity to Synthroid some patients may experience allergic reactions.
Who is contraindicated Synthroid:
- – Raised individual sensitivity towards the preparation
- – Thyrotoxicosis, which has not been treated
- – Acute myocardial infarction, acute myocarditis
- – Adrenal insufficiency, which is not treated
Be wary appoint the drug in diseases of the cardiovascular system, such as coronary heart disease (atherosclerosis, stenocardia, myocardial infarction in history), arrhythmia, diabetes mellitus, severe long-term hypothyroidism, malabsorption syndrome (you may need to adjust the dose).
Synthroid enhances the effect of anticoagulants, which may need to reduce their dose. The use of tricyclic antidepressants with Synthroid can lead to a strengthening of the action of antidepressants. Thyroid hormones can increase the need for insulin and oral hypoglycemic drugs. More frequent monitoring of blood glucose is recommended during the beginning of the treatment of Synthroid pills, as well as when changing the dose. Synthroid reduces the effects of cardiac glycosides.
While the use of colestyramine, Colestipol and aluminium hydroxide reduces the concentration of the drug in the plasma due to the inhibition of absorption him in the gut. During simultaneous usage with anabolic steroids, asparaginase, tamoxifen is possible pharmacokinetic interaction at the level of bonding with the protein.
In case of simultaneous administration of phenytoin, salicylates, clofibrate, furosemid in high doses increases the content is not associated with blood plasma proteins Synthroid and T4.
The use of drugs that contain estrogen increases the content of globulin, which may increase the need for Synthroid in some patients.
Almost every Synthroid reviewed indicate that it is a very effective drug.